Is nail removal indicated for onychomycosis?

Nail Removal for Onychomycosis: Not Routinely Indicated

Surgical nail removal is no longer indicated for onychomycosis; instead, chemical avulsion (debridement) of infected nail portions is useful as an adjunct to antifungal therapy, but systemic and/or topical antifungal medications remain the primary treatment approach 1.

Primary Treatment Approach

The modern management of onychomycosis does not rely on complete nail removal. Instead:

• First-line treatment: Oral terbinafine 250 mg daily (6 weeks for fingernails, 12-16 weeks for toenails) based on superior efficacy and tolerability 2
• Second-line: Itraconazole (continuous or pulse dosing) 2
• Topical therapy: Reserved for mild-to-moderate disease 3, 4

Role of Nail Debridement (Not Removal)

Chemical avulsion or mechanical debridement of infected nail material is recommended as an adjunct, not as primary therapy 5, 1:

• Chemical avulsion with urea 40% and bifonazole 1% removes fungally infected debris, improving antifungal penetration and treatment efficacy 6
• Once-weekly application achieves nail removal in approximately 11 days (versus 18.7 days with daily application) 6
• Atraumatic removal of diseased nail portions facilitates drug penetration and eliminates reinfection sites 5, 1

Why Surgical Extraction Is Obsolete

Surgical nail extraction is no longer indicated because 1:

• Modern antifungal agents achieve adequate nail penetration without complete removal
• Surgical avulsion causes unnecessary morbidity without improving outcomes
• Chemical methods are less traumatic and equally effective for debulking infected tissue

Optimal Treatment Algorithm

1. Confirm diagnosis mycologically before treatment 7, 3
2. Assess severity:
   • Mild-to-moderate: Consider topical therapy alone
   • Moderate-to-severe: Oral antifungals required 3, 4
3. Debride infected nail portions mechanically or chemically to enhance drug penetration 5
4. Initiate systemic therapy: Terbinafine as first choice 2
5. Consider combination therapy: Topical + oral agents may improve cure rates and shorten treatment duration 8

Important Caveats

• Baseline monitoring: Liver function tests and complete blood count recommended for patients with alcohol history, hepatitis, or hematological abnormalities before starting terbinafine 2
• Warn about taste disturbance: Rare but potentially permanent side effect of terbinafine 2
• Address predisposing factors: Treat tinea pedis, disinfect shoes/socks to prevent recurrence 5, 1
• High recurrence rates: Onychomycosis is chronic with 25-50% relapse rates; patient counseling on prevention is essential 8, 4

The shift from surgical removal to pharmacological management with selective debridement represents the evidence-based standard of care, prioritizing patient quality of life while maximizing cure rates.